Ardelean, Gavril - Buicu, Florin (szerk.): Satu Mare. Studii şi comunicări. Seria ştiinţele naturale 7. (2006)

Medicină

Satu Mare - Studii şi Comunicări Seria Ştiinţele Naturii Voi. VII (2006)

18. Vleming LJ, van der Pijl JW, Lemkes HH et al.: The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol 1999, 51: 133-140

19. Andersen S, Tarnow L, Cambien F et al.: Longterm renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? Diabetes Care 2003, 26:1501-1506

20. Bjorck S, Blohme G, Sylven C, Mulec H: Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy. Nephrol Dial Transplant 1997,12 Suppl 2: 67-70

21. Miura J, Uchigata Y, Yokoyama H, Omori Y, Iwamoto Y: Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1999,45: 41-49

22. Jacobsen P, Rossing K, Tarnow L et al: Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 1999, 7LS101-105

23. Hibberd ML, Millward BA, Demaine AG: The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complications 1997, 11:2-8

24. De Cosmo S, Margaglione M, Tassi V et al: ACE,PAI-l,decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev 1999, 15:247-253

25. Chowdhury TA, Dronsfield MJ, Kumar S et

al.: Examination of two genetic

polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996, 39: 1108-1114

26. Ringel J, Beige J, Kunz R, Disder A, Sharma AM: Genetic variants of the renninangiotensin system,diabetic nephropathy and hypertension. Diabetologia 1997, 40:193-199

27. Schmidt S, Schone N, Ritz E: Association of ACE gene polymorphism and diabetic nephropathyPThe Diabetic Nephropathy Study Group. Kidney Int 1995, 47:1176- 1181

28. Tarnow L, Kjeld T, Knudsen E, Major Pedersen A, Parving HH: Lack of synergism between long-term poor glycemic control and three gene polymorphisms of the rennin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Diabetologia 2000, 43:794-799

29. van Ittersum FJ, de Man AM, Thijssen S et al.: Genetic polymorphisms of the renninangiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000,15: 1000-1007

30. Freire MB, van Dijk DJ, Erman A, Boner G, Warram JH, Krolewski AS: DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin dependent diabetes mellitus. Nephrol Dial Transplant 1998, 13:2553-2558

31. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS: Diabetic nephropathy is associated with AGT polymorphism T235: results of a familybased study. Hypertension 1998, 31:627-631

32. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996, 45: 1204-1208

33. Hadjadj S, Belloum R, Bouhanick B et al.: Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 2001,12:541-549

34. Doria A, Onuma T, Gearin G, Freire MB, Warram JH, Krolewski AS: Angiotensinogen polymorphism M235T, hypertension and nephropathy in insulin-dependent diabetes. Hypertension 1996, 27:1134-1139

35. Schmidt S, Giessel R, Bergis KH et al:

Angiotensinogen gene M235T

polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1996,11:1755-1761

36. Corvol P, Jeunemaitre X: Molecular genetics

of human hypertension: role of

angiotensinogen. Endocr Rev 1997, 18: 662- 677

37. Doria A, Onuma T, Warram JH, Krolewski AS: Synergistic effect of angiotensin II typel receptor genotype and poor glycemic control on risk of nephropathy in IDDM. Diabetologia 1997, 40:1293-1299

38. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type

160